Home LiteratureArticle Details
PMID: 15967117 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.

Neoplasia (New York, N.Y.) ·Vol. 7 ·No. 4 ·2005-04-00 ·Pages 397-406

Dai C, Lyustikman Y, Shih A, Hu X, Fuller GN, Rosenblum M, Holland EC

Abstract

Chronic platelet-derived growth factor (PDGF) signaling in glial progenitors leads to the formation of oligodendrogliomas in mice, whereas chronic combined Ras and Akt signaling leads to astrocytomas. Different histologies of these tumors imply that the pathways activated by these two oncogenic stimulations are different, and that the apparent lineage of the tumor cells may result from specific signaling activity. Therefore, we have investigated the signaling effects of PDGF in culture and in gliomas in vivo. In culture, PDGF transiently activates ERK1/2 and Akt, and subsequently elevates p21 and PCNA expression similar to chronic PDGF autocrine signaling in cultured astrocytes and PDGF-induced oligodendrogliomas in vivo. Culture experiments show that autocrine PDGF stimulation, and combined active Ras and Akt generate signaling patterns that are in some ways mutually exclusive. Furthermore, forced Akt activity in the context of chronic PDGF stimulation results in cells with an astrocytic differentiation pattern both in culture and in vivo. These data imply that these two interconvertible signaling motifs are distinct in mice and lead to gliomas resembling the two major glioma histologies found in humans. The ability of signaling activity to convert tumor cells from one lineage to another presents a mechanism for the development of tumors apparently comprised of cells from multiple lineages.

MeSH Terms
Animals Astrocytoma/metabolism Blotting, Western Brain/metabolism Cell Differentiation Cell Lineage Enzyme Activation Glioma/metabolism Immunohistochemistry MAP Kinase Signaling System Mice Mice, Transgenic Mitogen-Activated Protein Kinase 1/metabolism Mitogen-Activated Protein Kinase 3/metabolism Oligodendroglioma/metabolism Phosphorylation Plasmids/metabolism Platelet-Derived Growth Factor/metabolism Protein Serine-Threonine Kinases/metabolism Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins p21(ras)/metabolism Signal Transduction Time Factors Transcriptional Activation ras Proteins/metabolism
Chemicals
Platelet-Derived Growth Factor Proto-Oncogene Proteins Protein Serine-Threonine Kinases Proto-Oncogene Proteins c-akt Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Proto-Oncogene Proteins p21(ras) ras Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Dai Chengkai
Department of Surgery (Neurosurgery), Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Lyustikman Yelena
Shih Alan
Hu Xiaoyi
Fuller Gregory N
Rosenblum Marc
Holland Eric C
References (35)
35 references, click to expand
  1. A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy.
    Oncogene. 1999 Nov 11;18(47):6540-5 PMID: 10597257
  2. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.
    Cell. 1994 Mar 25;76(6):1025-37 PMID: 8137421
  3. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
    Endocrinology. 2000 Apr;141(4):1545-53 PMID: 10746662
  4. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
    J Biol Chem. 2000 Apr 7;275(14):10285-90 PMID: 10744715
  5. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Cancer Res. 2000 Apr 15;60(8):2178-89 PMID: 10786682
  6. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.
    Cancer Res. 1994 May 15;54(10):2794-9 PMID: 8168112
  7. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation.
    EMBO J. 1995 Mar 1;14(5):951-62 PMID: 7889942
  8. Molecular cloning of human p38 MAP kinase.
    Biochim Biophys Acta. 1995 Mar 16;1265(2-3):224-7 PMID: 7696354
  9. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.
    Nature. 1995 Aug 17;376(6541):599-602 PMID: 7637810
  10. A nestin-negative precursor cell from the adult mouse brain gives rise to neurons and glia.
    Glia. 1997 Dec;21(4):399-407 PMID: 9419015
  11. Proliferation of human malignant astrocytomas is dependent on Ras activation.
    Oncogene. 1997 Dec 4;15(23):2755-65 PMID: 9419966
  12. Platelet-derived growth factor and its receptor expression in human oligodendrogliomas.
    Neurosurgery. 1998 Feb;42(2):341-6 PMID: 9482185
  13. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
    Curr Biol. 1998 Oct 22;8(21):1195-8 PMID: 9799739
  14. In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.
    Am J Pathol. 1998 Nov;153(5):1411-23 PMID: 9811332
  15. PCNA, a multifunctional ring on DNA.
    Biochim Biophys Acta. 1998 Nov 26;1443(1-2):23-39 PMID: 9838028
  16. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
    EMBO J. 1999 Mar 15;18(6):1571-83 PMID: 10075928
  17. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model.
    Nat Med. 2004 Nov;10(11):1257-60 PMID: 15502845
  18. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
    Nat Genet. 2000 May;25(1):55-7 PMID: 10802656
  19. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.
    J Neuropathol Exp Neurol. 2000 Jun;59(6):495-503 PMID: 10850862
  20. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.
    Annu Rev Biochem. 1999;68:965-1014 PMID: 10872470
  21. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Genes Dev. 2001 Aug 1;15(15):1913-25 PMID: 11485986
  22. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.
    Cancer Res. 2001 Aug 15;61(16):6234-8 PMID: 11507077
  23. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
    Biochem Biophys Res Commun. 2001 Oct 19;288(1):205-11 PMID: 11594774
  24. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.
    Glia. 2002 Sep;39(3):193-206 PMID: 12203386
  25. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Cancer Res. 2002 Oct 1;62(19):5551-8 PMID: 12359767
  26. Cancerous stem cells can arise from pediatric brain tumors.
    Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83 PMID: 14645703
  27. Cyclin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell division.
    FEBS Lett. 1987 Aug 10;220(1):1-7 PMID: 2886367
  28. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
    Cancer Res. 1988 Jul 15;48(14):3910-8 PMID: 2454731
  29. Differentiation of a bipotential glial progenitor cell: what controls the timing and the choice of developmental pathway?
    J Cell Sci Suppl. 1988;10:77-83 PMID: 3077944
  30. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues.
    Proc Natl Acad Sci U S A. 1990 Aug;87(15):5710-4 PMID: 2377607
  31. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.
    Proc Natl Acad Sci U S A. 1990 Aug;87(16):6368-72 PMID: 2201028
  32. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.
    Cancer Res. 1992 Aug 15;52(16):4550-3 PMID: 1322795
  33. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.
    Neurosurgery. 1992 Oct;31(4):717-24; discussion 724 PMID: 1407458
  34. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.
    Int J Cancer. 1994 Jan 2;56(1):72-7 PMID: 8262681
  35. p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis.
    Cancer Res. 2000 Feb 1;60(3):679-84 PMID: 10676653
Article Info
Journal
Neoplasia (New York, N.Y.)
Abbr.
Neoplasia
ISSN
1522-8002
Published
2005-04-00
Pages
397-406
Language
English
Region
United States
NLM ID
100886622
PMCID
PMC1501153
Subset
IM
Grants
NCI NIH HHS · U01CA894314-1 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]